1. HOME
2. Research Insight
3. Thermo Fisher Scientific, Inc.(US),Danaher Corporation (US) and Agilent Technologies, Inc (US) are the Major Players in the Metabolomics Market

The global metabolomics market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period. Market growth is driven largely by the ongoing innovations in metabolomics, continuous support in the form of investments and grants from the government & private sectors, and increasing demand for personalized medicines.

The major players operating in this market are Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US), Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), JASCO, Inc. (US) among others

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific, Inc.(US)

Thermo Fisher Scientific, Inc.is a leading player in the global metabolomics market owing to its extensive portfolio of metabolomics instruments and services. Thermo Fisher provides a wide range of GC, LC, GC-MS, LC-MS, NMR spectrometer, and bioinformatics tools for metabolite analysis. The Analytical Technologies business segment of the company provides metabolomics solutions. The company has a strong presence in the US, which is the largest market for metabolomics. The company strategically invests in acquisitions, collaborations, and product innovations to increase its portfolio for mass spectrometry and chromatography.

Danaher Corporation (US)

Danaher Corporation operates in the metabolomics market through its subsidiary AB SCIEX. AB SCIEX manufactures and markets mass spectrometry systems and software for drug discovery research. Danaher has a strong presence in over 50 countries worldwide through its R&D, manufacturing, sales, distribution, services, and administrative facilities. To maintain its position in the market, Danaher focuses on product launches and strategic acquisition of businesses for expanding its portfolio in the life sciences and diagnostics sectors. In this regard, Danaher Corporation launched a breakthrough technology solution—CESI-MS—to expand its separation solutions portfolio. The CESI-MS workflow is the first commercially available ultra-low-flow separation and ESI module for biologics. It is a high-performance, high-resolution, accurate mass instrument used in biopharmaceuticals development.

Agilent Technologies, Inc (US)

Agilent Technologies is one of the leading provider of metabolomics instruments and services. The company has maintained its leadership position in the market through its strong distribution networks across North America, Europe, and Asia Pacific. Through R&D investments, the company continues to introduce innovative and differentiated products in the market. To keep up with technological advancements in separation systems, the company focuses on continuous improvements in its products. The company offers complete LC/MS solutions for the life sciences industry. The company focuses on agreements, co-marketing strategies, and collaborations to expand its business operations and increase its market share.

Related Reports:

Metabolomics Market by Product (GC,UPLC, CE, Surface based Mass Analysis), Application (Biomarker Discovery, Drug Discovery,Functional Genomics), Indication (Cardiology, Oncology,Inborn Errors), End User (Academic Institute,CROs) - Global Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]